Table 8.

Change in HbA1c with DPP-4i use, N = 47 (patients without insulin)

Type of DPP-4i	n (%)	Pre DPP-4i use	Post DPP-4i use	Mean difference (95% CI)	P value£	P value¥
Vildagliptin	20 (42.6)	7.7 ± 0.9	6.7 ± 0.8	1.03 (0.37, 1.68)	0.004*	0.104¢
Sitagliptin	13 (27.7)	8.8 ± 2.1	7.1 ± 1.4	1.69 (0.25, 3.13)	0.025*
Saxagliptin	13 (27.7)	7.8 ± 1.3	7.4 ± 1.1	0.32(−0.06, 0.71)	0.094
Linagliptin	1 (2.1)

^£Paired T-test conducted to compare pre and post DPP-4i HbA1c

^¥ANOVA conducted to compare the HbA1c difference between the groups

Values reported as mean ± SD

*p value is significant at< 0.05

Linagliptin omitted from analysis as n = 1